Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II—results
- 1 December 2000
- Vol. 56 (6) , 981-987
- https://doi.org/10.1016/s0090-4295(00)00829-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part I—methodsUrology, 2000
- Impact of drug therapy on benign prostatic hyperplasia-specific quality of lifeUrology, 1999
- PROSPECTIVE RANDOMIZED COMPARISON OF HIGH ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY VERSUS alpha-BLOCKER TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1999
- Transurethral microwave thermotherapy: what role should it play versus medical management in the treatment of benign prostatic hyperplasia?Urology, 1998
- A pharmacoeconomic analysis of patients with symptoms of benign prostatic hyperplasia.PharmacoEconomics, 1997
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Patient satisfaction with finasteride in the treatment of symptomatic benign prostatic hyperplasiaClinical Therapeutics, 1996
- The International Terazosin Trial: A Multicentre Study of the Long-Term Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1996
- Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasiaUrology, 1995
- Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical CompaniesNew England Journal of Medicine, 1991